Washington University Therapeutics (WT) CRS (2101) — St Louis, Missouri

Washington University Therapeutics (WT) CRS (2101) is a clinical research site located in St Louis, Missouri, United States 63110.

Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.

Washington University Therapeutics (WT) CRS (2101) has participated in 3 clinical trials with 1 currently active.

Therapeutic areas: HIV Infections, HIV-1-infection, HIV I Infection.

Sponsors: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections, National Institute of Allergy and Infectious Diseases (NIAID).

Sponsor Feasibility Report

Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Washington University Therapeutics (WT) CRS (2101)?

Washington University Therapeutics (WT) CRS (2101) has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Washington University Therapeutics (WT) CRS (2101) conducted?

Washington University Therapeutics (WT) CRS (2101) has 3 clinical trials on record, with 1 currently active. Their work covers HIV Infections, HIV-1-infection, HIV I Infection.

Is Washington University Therapeutics (WT) CRS (2101) accredited by Crixeo Health?

Washington University Therapeutics (WT) CRS (2101) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Washington University Therapeutics (WT) CRS (2101)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.